AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
58 hedge funds and large institutions have $16.5M invested in Asterias Biotherapeutics Inc. Series A in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 14 closing their positions.
Holders
58
Holders Change
-5
Holders Change %
-7.94%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
14
Reduced
12
Closed
14
Calls
–
Puts
$121K
Net Calls
-$121K
Net Calls Change
+$23K
Top Buyers
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.91M |
| 2 |
2
Millennium Management
New York
|
$0 |
| 3 |
CS
3
Credit Suisse
Zurich,
Switzerland
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
5
Citigroup
New York
|
$7K |
